PolyNovo Limited (ASX:PNV) Announces Strong 1H FY25 Trading Results
PolyNovo Limited (ASX:PNV) reports a strong 22.8% revenue increase in 1H FY25, with significant growth in the US and worldwide sales.
Category: Healthcare
Emmerson Resources Limited (ASX: ERM) Updates on White Devil Gold Project
Emmerson Resources Limited announces expanded drilling at White Devil Gold Project with upcoming resource estimates and assay results.
Ardea Resources Limited (ASX:ARL) DFS Update on Kalgoorlie Nickel Project
Ardea Resources updates on the DFS for its Kalgoorlie Nickel Project, showcasing drilling progress and team recruitment efforts.
Immuron Limited (ASX:IMC) Reports Strong Travelan® Sales Growth
Immuron Limited (ASX: IMC) reports a 249% increase in Travelan® sales, indicating significant growth in both domestic and international markets.
Reach Resources Limited (ASX: RR1) December 2024 Quarterly Activities Report
Reach Resources (ASX: RR1) reveals strong gold and REE potential in December 2024 quarterly activities report.
Neurizon Therapeutics Limited (ASX: NUZ) Investigational New Drug Application Update
Neurizon Therapeutics Limited announces FDA has placed its NUZ-001 IND application under clinical hold, seeking further information.
Archer Materials (ASX:AXE) Reports Debt-Free Q2 FY25 Activities and Financials
Archer Materials (ASX:AXE) reports progress in quantum projects and TMR sensor technology with a strong cash position in Q2 FY25.
Singular Health Group (ASX:SHG) Advances Remote Medical Imaging Initiative
Singular Health (ASX: SHG) confirms successful Phase 1 completion with PNS, advancing to Phase 2 in its medical imaging project.
Lynas Rare Earths Ltd (ASX:LYC) Reports Strong Q2 FY25 Results
Lynas Rare Earths Ltd (ASX:LYC) announces significant revenue growth and operational advancements for Q2 FY25 despite market challenges.
Telix Pharmaceuticals Limited (ASX:TLX) Receives European Approval for Illuccix®
Telix Pharmaceuticals Limited announces European approval for Illuccix®, paving the way for its commercial launch in prostate cancer imaging.